Skip to main content
PMC home page
Public Health Reports logoLink to Public Health Reports
. 1998 Jun;113(Suppl 1):4–18.

HIV prevention with drug-using populations--current status and future prospects: introduction and overview.

R H Needle 1, S L Coyle 1, J Normand 1, E Lambert 1, H Cesari 1
PMCID: PMC1307723  PMID: 9722806

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auerbach D. M., Darrow W. W., Jaffe H. W., Curran J. W. Cluster of cases of the acquired immune deficiency syndrome. Patients linked by sexual contact. Am J Med. 1984 Mar;76(3):487–492. doi: 10.1016/0002-9343(84)90668-5. [DOI] [PubMed] [Google Scholar]
  2. Ball J. C., Lange W. R., Myers C. P., Friedman S. R. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav. 1988 Sep;29(3):214–226. [PubMed] [Google Scholar]
  3. Brown B. S., Needle R. H. Modifying the process of treatment to meet the threat of AIDS. Int J Addict. 1994 Nov;29(13):1739–1752. doi: 10.3109/10826089409047959. [DOI] [PubMed] [Google Scholar]
  4. Centers for Disease Control and Prevention (CDC) Update: syringe-exchange programs--United States, 1996. MMWR Morb Mortal Wkly Rep. 1997 Jun 20;46(24):565–568. [PubMed] [Google Scholar]
  5. Friedland G. H., Harris C., Butkus-Small C., Shine D., Moll B., Darrow W., Klein R. S. Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns. Arch Intern Med. 1985 Aug;145(8):1413–1417. [PubMed] [Google Scholar]
  6. Friedman S. R., Des Jarlais D. C., Sotheran J. L. AIDS health education for intravenous drug users. Health Educ Q. 1986 Winter;13(4):383–393. doi: 10.1177/109019818601300409. [DOI] [PubMed] [Google Scholar]
  7. Friedman S. R., Jose B., Deren S., Des Jarlais D. C., Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium. Am J Epidemiol. 1995 Oct 15;142(8):864–874. doi: 10.1093/oxfordjournals.aje.a117726. [DOI] [PubMed] [Google Scholar]
  8. Hagan H., Jarlais D. C., Friedman S. R., Purchase D., Alter M. J. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health. 1995 Nov;85(11):1531–1537. doi: 10.2105/ajph.85.11.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hahn R. A., Onorato I. M., Jones T. S., Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA. 1989 May 12;261(18):2677–2684. [PubMed] [Google Scholar]
  10. Heimer R., Khoshnood K., Jariwala-Freeman B., Duncan B., Harima Y. Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens. J Infect Dis. 1996 Apr;173(4):997–1000. doi: 10.1093/infdis/173.4.997. [DOI] [PubMed] [Google Scholar]
  11. Heimer R., Lopes M. Syringe and needle exchange to prevent HIV infection. JAMA. 1994 Jun 15;271(23):1825–1827. doi: 10.1001/jama.271.23.1825a. [DOI] [PubMed] [Google Scholar]
  12. Hubbard R. L., Marsden M. E., Cavanaugh E., Rachal J. V., Ginzburg H. M. Role of drug-abuse treatment in limiting the spread of AIDS. Rev Infect Dis. 1988 Mar-Apr;10(2):377–384. doi: 10.1093/clinids/10.2.377. [DOI] [PubMed] [Google Scholar]
  13. Hughes P. H., Crawford G. A. A contagious disease model for researching and intervening in heroin epidemics. Arch Gen Psychiatry. 1972 Aug;27(2):149–155. doi: 10.1001/archpsyc.1972.01750260005001. [DOI] [PubMed] [Google Scholar]
  14. Klovdahl A. S. Social networks and the spread of infectious diseases: the AIDS example. Soc Sci Med. 1985;21(11):1203–1216. doi: 10.1016/0277-9536(85)90269-2. [DOI] [PubMed] [Google Scholar]
  15. Marmor M., Des Jarlais D. C., Friedman S. R., Lyden M., el-Sadr W. The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers. J Subst Abuse Treat. 1984;1(4):237–247. doi: 10.1016/0740-5472(84)90002-3. [DOI] [PubMed] [Google Scholar]
  16. Metzger D. S., Woody G. E., McLellan A. T., O'Brien C. P., Druley P., Navaline H., DePhilippis D., Stolley P., Abrutyn E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr. 1993 Sep;6(9):1049–1056. [PubMed] [Google Scholar]
  18. Paone D., Caloir S., Shi Q., Des Jarlais D. C. Sex, drugs, and syringe exchange in New York City: women's experiences. J Am Med Womens Assoc. 1995 May-Aug;50(3-4):109–114. [PubMed] [Google Scholar]
  19. Pickens R. W., Fletcher B. W. Improving drug abuse treatment. Overview of treatment issues. NIDA Res Monogr. 1991;106:1–19. [PubMed] [Google Scholar]
  20. Rothenberg R., Narramore J. The relevance of social network concepts to sexually transmitted disease control. Sex Transm Dis. 1996 Jan-Feb;23(1):24–29. doi: 10.1097/00007435-199601000-00007. [DOI] [PubMed] [Google Scholar]
  21. Schuster C. R. Intravenous drug use and AIDS prevention. Public Health Rep. 1988 May-Jun;103(3):261–266. [PMC free article] [PubMed] [Google Scholar]
  22. Simpson D. D. Treatment for drug abuse. Follow-up outcomes and length of time spent. Arch Gen Psychiatry. 1981 Aug;38(8):875–880. doi: 10.1001/archpsyc.1981.01780330033003. [DOI] [PubMed] [Google Scholar]
  23. Watters J. K., Downing M., Case P., Lorvick J., Cheng Y. T., Fergusson B. AIDS prevention for intravenous drug users in the community: street-based education and risk behavior. Am J Community Psychol. 1990 Aug;18(4):587–596. doi: 10.1007/BF00938061. [DOI] [PubMed] [Google Scholar]
  24. Wiebel W. W., Jimenez A., Johnson W., Ouellet L., Jovanovic B., Lampinen T., Murray J., O'Brien M. U. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):282–289. doi: 10.1097/00042560-199607000-00008. [DOI] [PubMed] [Google Scholar]

Articles from Public Health Reports are provided here courtesy of SAGE Publications

RESOURCES